Fibromyalgia: From A - Z
illnesses exact the same toll. Alzheimer's is different from MS, heart disease is different from Parkinson's, stroke is different from accident. But all well spouses face similar problems of anger, guilt, fear, isolation, grief, and financial threat whether they are full-time caregivers or whether their partners have only moderately disabling illnesses. Well Spouse is a national, not for profit membership organization which gives support to wives, husbands, and partners of the chronically ill and/or disabled. Well Spouse support groups meet monthly. Here, our members can share their thoughts and feelings openly with others facing similar circumstances in a supportive, non-judgmental environment. WS support groups are also an excellent source for information on a wide-range of practical issues facing spousal caregivers. Well Spouse support groups exist or are being formed in many areas of the country. To contact a support group near you or to learn how to start a group, please go to our "SUPPORT GROUPS" page." wellspouse.org
Xyrem: for Fibromyalgia "04-21-2004 Investigational New Drug Application Under Review by FDA MINNEAPOLIS--(BUSINESS WIRE)--April 21, 2004--Orphan Medical, Inc. (Nasdaq:ORPH) ..."today announced results for the first quarter ended March 31, 2004. Revenue for the quarter was $5.4 million, which includes $1 million of licensing revenue. The $4.4 million in product revenue was highlighted by growth in Xyrem(R) (sodium oxybate) oral solution and strong Antizol(R) (fomepizole) Injection sales. Xyrem revenue for the quarter was $1.7 million compared to $0.6 million in the prior year. Orphan Medical reported a net loss to common shareholders of $4.3 million, or $0.40 per share, compared to a net loss of $4.1 million, or $0.39 per share, in the first quarter of 2003. The Company also announced that it has filed an Investigational New Drug (IND) Application to begin a clinical trial to assess Xyrem in the treatment of fibromyalgia syndrome. The Food and Drug Administration (FDA) has received the application and has begun its statutory review of the IND. The Company expects to initiate the trial during the second quarter of 2004." immunesupport.com
Yeast Infections and Candida information from Yeast Infection Resource. "Yeast infections are likely to affect three out of four women at least once in their lifetime, yet they remain an embarrassing topic to discuss. Where do women turn for information about this uncomfortable condition? Experts have come together to bring you Yeast Infection Resource.com - a Web site about the causes, symptoms, and treatment options available for yeast
Latest Articles